Novel GABAA Agonist Entities: Pharmacological Investigation and Molecular Modeling Study of Thiazolo- and Thiadiazolo-[3,2-a][1,3] diazepine Analogs

Author(s):  
Hussein I. El-Subbagh

Abstract:: Thiazolo- and thiadiazolo-[3,2-a][1,3]diazepines and their patented derivatives, tested with diverse CNS pharmacological activities, constitute an important class of compounds for new drug development. Therefore, research efforts were continued to design, synthesize, and evaluate compounds for their ultra-short, short-acting hypnotic, anticonvulsant, and neuromuscular blocking activities. The present review provides a summary of the work accomplished by these heterocycles and their biological evaluation.

Author(s):  
Cheng-Peng Sun ◽  
Zi-Li Jia ◽  
Xiao-Kui Huo ◽  
Xiang-Ge Tian ◽  
Lei Feng ◽  
...  

As a genus of the Asteraceae, Inula is widely distributed all over the world, and several of them are being used in traditional medicines. A number of metabolites were isolated from Inula species, and some of these have shown to possess ranges of pharmacological activities. The genus Inula contains abundant sesquiterpenoids, such as eudesmanes, xanthanes, and sesquiterpenoid dimers and trimers. In addition, other types of terpenoids, flavonoids, and lignins also exist in the genus Inula. Since 2010, more than 300 new secondary metabolites, including several known natural products that were isolated for the first time from the genus Inula. Most of them exhibited potential bioactivities in various diseases. The review aimed to summarize the advance of recent researches (2010–2020) on phytochemical constituents, biosynthesis, and pharmacological properties of the genus Inula for providing a scientific basis and supporting its application and exploitation for new drug development.


Author(s):  
Shyam Baboo Prasad

Embelin is a benzoquinone compound, present mainly in Embelia species. Embelin is also reported in Lysimachia punctate, Ardisia humilis, Rapanea umbellate, Cannarus richiei, Myrsine Africana and Myrsine capitellata. Embelin has demonstrated wide range of pharmacological activities including; antidepressant, anticancer, antifertility, antidiabetic, antioxidant and analgesic. Embelin shown other activities also such as antihyperlipidemic, antifungal, antihyperhomocysteinemic, anthelminthic, anticonvulsant, antibacterial, hepatoprotective, wound healing and anxiolytic activity. Recent studies, have thrown light on anti-arthritis and antiulcer activities of the benzoquinone. The present review, discusses pharmacological investigations on embelin, with potential for drug-development.


Author(s):  
Swati Pawar ◽  
Kapil Kumar ◽  
Manish K. Gupta ◽  
Ravindra K. Rawal

: Fused triazole had explored their apartment as one of the important class of heterocycles, extensively used by chemists due to their diverse pharmacological activities in both synthetic organic chemistry and systemic biological field. Various methodologies for targets containing fused thiazole scaffold were reported in literature with their potent pharmacological activities. Thiazole and its hybrid compounds had attracted attention to design novel anticancer agents. Currently, various fused thiazole containing compounds are available in market to cure cancer. This review focus on different methodologies and anticancer activity of various fused and tethered thiazole containing compounds. The anticancer property of different novel entities was extensively studied and can be surely proved a promising lead for the drug development.


2019 ◽  
Vol 11 ◽  
Author(s):  
Bhawna Chopra ◽  
Ashwani K. Dhingra ◽  
Deo Nandan Prasad

Objective: Imidazole is a heterocyclic moiety having immense biological importance. Since from ancient years, imidazole nucleus was found to be promising moiety in field of chemistry. Preliminaryin vitroand in vivostudies have provided valuable scientific evidencefor its use. Subsequently, imidazole constitutes for new class of compounds for new drug development as presence of this nucleus in diverse therapeutic categories viz; antimicrobial, anti-inflammatory, anticancer, immunomodulator, antiviral etchas made it an interesting moiety for design and development of new pharmacological agents. Thus this review aims to summarize the reported molecular entities which were synthesized by using conventional as well as microwave processes, chemistry and biological potential of imidazole containing heterocyclic molecules while identifying potential areas of further research of imidazole. Key findings: The review comprises literature pertaining to the evidence based pharmacological or therapeutic potential of imidazole from may many years using published articles and worldwide databases. Various pharmacological experiments using different models exclusively proven the potential of imidazole. Summary: Thus, focusing on discovery and development of new imidazole nucleus based molecules at a faster rate; there is a need to check out the previous information available in market in the field of medicinal chemistry. So the present review aims ornately pronounced the therapeutic worth of imidazole and its analogs.


2016 ◽  
Vol 124 ◽  
pp. 237-247 ◽  
Author(s):  
Hussein I. El-Subbagh ◽  
Ghada S. Hassan ◽  
Kamal E.H. El-Taher ◽  
Shahenda M. El-Messery ◽  
Adel S. Al-Azab ◽  
...  

2020 ◽  
Vol 27 (40) ◽  
pp. 6864-6887 ◽  
Author(s):  
Mohd Adil Shareef ◽  
Irfan Khan ◽  
Bathini Nagendra Babu ◽  
Ahmed Kamal

Background:: Imidazo[2,1-b]thiazole, a well-known fused five-membered hetrocycle is one of the most promising and versatile moieties in the area of medicinal chemistry. Derivatives of imidazo[2,1-b]thiazole have been investigated for the development of new derivatives that exhibit diverse pharmacological activities. This fused heterocycle is also a part of a number of therapeutic agents. Objective:: To review the extensive pharmacological activities of imidazo[2,1-b]thiazole derivatives and the new molecules developed between 2000-2018 and their usefulness. Method:: Thorough literature review of all relevant papers and patents was conducted. Conclusion:: The present review, covering a number of aspects, is expected to provide useful insights in the design of imidazo[2,1-b]thiazole-based compounds and would inspire the medicinal chemists for a comprehensive and target-oriented information to achieve a major breakthrough in the development of clinically viable candidates.


Author(s):  
Ahmad Ebadi ◽  
Mehdi Khoshneviszadeh ◽  
Katayoun Javidnia ◽  
Mohammad Hossein Ghahremani ◽  
Omidreza Firuzi ◽  
...  

2019 ◽  
Vol 15 (2) ◽  
pp. 175-185 ◽  
Author(s):  
Momin Khan ◽  
Sehrish Khan ◽  
Amir Ul Mulk ◽  
Anis Ur Rahman ◽  
Abdul Wadood ◽  
...  

Background:Barbituric acid derivatives are a versatile group of compounds which are identified as potential pharmacophores for the treatment of anxiety, epilepsy and other psychiatric disorders. They are also used as anesthetics and have sound effects on the motor and sensory functions. Barbiturates are malonylurea derivatives with a variety of substituents at C-5 position showing resemblance with nitrogen and sulfur containing compounds like thiouracil which exhibited potent anticancer and antiviral activities. Recently, barbituric acid derivatives have also received great interest for applications in nanoscience.Objective:Synthesis of 5-arylidene-N,N-diethylthiobarbiturates, biological evaluation as potential α-glucosidase inhibitors and molecular modeling.Methods:In the present study, N,N-Diethylthiobarbituric acid derivatives were synthesized by refluxing of N,N-diethylthiobarbituric acid and different aromatic aldehydes in distilled water. In a typical reaction; a mixture of N,N-diethylthiobarbituric acid 0.20 g (1 mmol) and 5-bromo-2- hydroxybenzaldehyde 0.199 g (1 mmol) mixed in 10 mL distilled water and reflux for 30 minutes. After completion of the reaction, the corresponding product 1 was filtered and dried and yield calculated. It was crystallized from ethanol. The structures of synthesized compounds 1-25 were carried out by using 1H, 13C NMR, EI spectroscopy and CHN analysis used for the determination of their structures. The α-glucosidase inhibition assay was performed as given by Chapdelaine et al., with slight modifications and optimization.Results:Our newly synthesized compounds showed a varying degree of α-glucosidase inhibition and at least four of them were found as potent inhibitors. Compounds 6, 5, 17, 11 exhibited IC50 values (Mean±SEM) of 0.0006 ± 0.0002, 18.91 ± 0.005, 19.18 ± 0.002, 36.91 ± 0.003 µM, respectively, as compared to standard acarbose (IC50, 38.25 ± 0.12 µM).Conclusion:Our present study has shown that compounds 6, 5, 17, 11 exhibited IC50 values of 0.0006 ± 0.0002, 18.91 ± 0.005, 19.18 ± 0.002, 36.91 ± 0.003 µM, respectively. The studies were supported by in silico data analysis.


Sign in / Sign up

Export Citation Format

Share Document